$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
What the Options Market Tells Us About DexCom
Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 P.m. Eastern Time.
Is DexCom a Millionaire Maker?
Piper Sandler Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
Piper Sandler analyst Matthew O'Brien maintains $DexCom(DXCM.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 50.5% and a
Investing in DexCom (NASDAQ:DXCM) Five Years Ago Would Have Delivered You a 89% Gain
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
'No Pain, No Gain,' Just Look at Stocks That Jumped Nearly 1,000% in a 5-year Time Span
Smart Home Healthcare Market Assessment: A Deep Dive Into Historical, Current, and Forecasted Analytics 2020-2030; Featuring Roche, Dexcom, Apollo Global Management, VitalConnect & More
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
Dexcom Director Bridgette P. Heller Sells Shares Worth $70,000
Senseonics Eversense 365 Glucose Monitor Cleared in the U.S.
Oppenheimer Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $115
Oppenheimer analyst Steven Lichtman maintains $DexCom(DXCM.US)$ with a buy rating, and maintains the target price at $115.According to TipRanks data, the analyst has a success rate of 53.0% and a
Wells Fargo Remains a Buy on Dexcom (DXCM)
Roche Stock to Benefit From Accu-Chek Smartguide Launch in Europe
Is DexCom Stock Underperforming the S&P 500?
Three 'Buys,' Three 'Sells,' and a 'Hold,' by Oppenheimer Analysts
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
Analysts' Top Healthcare Picks: Dexcom (DXCM), Ascendis Pharma (ASND)